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Available online 5 November 2016Peripheral bloodmononuclear cells (PBMCs) were collected from an 8-year old female patient affected by ische-
mic Moyamoya disease (MMD). Patient's PBMCs were reprogrammed using Sendai virus particles delivering the
four Yamanaka factors. The footprint free hiPSC line expressed the major pluripotency markers and exhibited a
normal karyotype. Cells were competent to give rise to progeny of differentiated cells belonging to the 3 germ
layers. This hiPSC line represents a good tool to in vitromodelMMD in order to shed light on the cellular andmo-
lecular mechanisms responsible for the occurrence of this syndrome.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Resource table.Li
ame of stem cell
line MMD ISCH#6 iPSC line
stitutionIn
EDepartment of Neuroscience and Surgery of the Nervous
System, Papa Giovanni XXIII Hospital, Bergamo, Italy;
Centre for Integrative Biology, Università degli Studi di
Trento, Trento, Italyerson who created
resourceLuigi Andrea Lanterna, Luciano Contiontact person and
emailLuigi Andrea Lanterna, l.lanterna@gmail.com; Luciano
Conti, Luciano.Conti@unitn.it.ate archived/stock
dateOctober 2015rigin Peripheral blood mononuclear cells (PBMCs)
pe of resource Biological reagent: induced pluripotent stem cell (iPSC);
derived from a sporadic ischemic Moyamoya disease
(MMD) patientb-type Induced pluripotent stem cells (iPSCs)
ey transcription
factorshOCT4, hSOX2, hc-Myc, hKLF4 (CytoTune™-iPS 2.0 Sendai
Reprogramming Kit - Thermo Fisher Scientiﬁc)uthentication Identity and purity of the cell line was conﬁrmed by the
following tests: expression of pluripotency genes by2708@cumc.columbia.edu
no.Conti@unitn.it (L. Conti).
iology, LIFE and BRAIN Center,
opment, Columbia University,
. This is an open access article under the CC BY license (http://RT-PCR, western blot and immunoﬂuorescence, expression
of SeV speciﬁc genome by RT-PCR, chromosome stability
by karyotyping, in vitro differentiation in the 3 germ-layer
derivativesnk to related
literature/formation in public
databases/thics Patient informed consent obtained; Ethics Review
Board-competent authority approval was obtained from
the Papa Giovanni XXIII Hospital Ethical Board1. Resource details
Blood sample was collected from an 8-year old female patient with
Moyamoya disease (MMD; Papa Giovanni XXIII Hospital, Bergamo,
Italy). Patient presented a minor stroke andmultiple transient ischemic
attacks (TIA) characterized by transientmotor deﬁcits of the right hand.
The MR showed an infarct in the fronto-parietal region on the left side
and multiple small ischemic lesions in the deep and superﬁcial water-
shed areas of both hemispheres. A computed tomography angiography
demonstrated the complete occlusion of the internal carotid artery dis-
tal to the origin of the anterior choroidal artery on both sides with the
compensatory hypertrophy of the basal lenticulostriate arteries, indica-
tive for MMD. A postoperative digital subtraction angiographywas con-
sistent with the diagnosis of MMD.
Puriﬁed patient's PBMCs were transduced with Sendai virus parti-
cles (Yang et al., 2008–2012), delivering the four Yamanaka factorscreativecommons.org/licenses/by/4.0/).
Fig. 1. Characterization of MMD ISCH#6 hiPSC line. A: Representative picture of a MMD ISCH-#6 hiPSC colony (5×) and its karyogram showing a normal diploid 46, XY karyotypewith no
evident cytogenetic aberrations. Immunophenotypical characterization showing the expression of thepluripotencymarkers OCT4,Nanog, TRA-1-60, SOX2 (40×). B: RT-PCRdisplaying the
expression of the pluripotency-associated genes in MMD ISCH#6 iPSCs cultures and in another MMD ISCH hiPSC clone (#31) derived from the same patient at passages 0 and 10. Lack of
the Sendai virus genome maintenance is shown in passage 10 cultures. Commercial hiPSCs were used as positive control for pluripotency-associated genes. C: Western blot analysis
showing protein expression levels of pluripotency-associated markers in MMD ISCH#6 iPSCs and in other clones derived from the same patient.
620 M. Cardano et al. / Stem Cell Research 17 (2016) 619–622(OCT4, SOX2, KLF4, and c-Myc; Takahashi et al., 2007). Colonies with
typical iPSC-like morphology appeared 10–12 d after transduction and
some of them were picked 16–18 d later. Clones were expanded and
further characterized. One of the isolated clones gave rise to the MMD
ISCH#6 iPSC line, characterized by homogeneous colonies, normal dip-
loid 46, XX karyotype, without detectable abnormalities, and stable
expression of the pluripotency markers OCT4, Nanog, SOX2 and TRA-
1-60, veriﬁed by both immunoﬂuorescence, RT-PCR and western blot
(Fig. 1A–C) (Itskovitz-Eldor et al., 2000; Carpenter et al., 2003). Absence
of residual episomal Sendai virus was conﬁrmed at passage 10 (Fusaki
et al., 2009), suggesting that the expression of OCT4, SOX2, KLF4, and
c-Myc was indicative of a successful complete reprogramming process
(Fig. 1B).
Differentiation potential of the MMD ISCH#6 iPSC line was assessed
by Embryoid Body assay. Differentiated 14-day old cultures exhibited
the presence of β3-Tubulin (ectoderm), α-SMA (mesoderm) and
TROMA-1 (endoderm) immunopositive cells (Fig. 2A), thus conﬁrming
the pluripotent nature of the cells (Itskovitz-Eldor et al., 2000;
Carpenter et al., 2003). The differentiation competency of this cell line
was equivalent to that observed for a commercial hiPSC line, as shown
by the comparable expression levels of the 3 germ layers markers
FGF5 (ectoderm), Nestin (neuro-ectoderm), T-Brachyury (mesoderm),
SOX-17 (endoderm) assessed by qRT-PCR (Fig. 2B).Fig. 2. In vitro differentiation ofMMD ISCH#6 iPSC line. A: Picture of Embryoid Body after 4 d of
(α-SMA) and endodermal (TROMA-1) germ layer markers (20×). B: qRT-PCR showing a com
(neuro-ectoderm), T-Brachyury (mesoderm) and SOX-17 (endoderm) between 14 d different2. Materials and methods
2.1. PBMCs collection and freezing
Patient's PBMCswere isolated in BD Vacutainer CPT Cell Preparation
tubes and separated by centrifugation (30 min, 1800g at room temper-
ature). They were collected in 35 mL of PBS, centrifuged at 300g for
15 min at room temperature. Stocks of 2 ∗ 106 cells were cryopreserved
in fetal bovine serum (FBS) with 10% DMSO.
2.2. PBMCs thawing and reprogramming with Sendai virus particles
Cells were thawed in a well of a 24 well-plate and cultured in the
PBMC expansion medium, composed by StemPro-34 Serum Free Medi-
umBasalMedium (Thermo Fisher Scientiﬁc), StemPro-34Nutrient Sup-
plement, 200 mM GlutaMAX (Thermo Fisher Scientiﬁc), 1% Penicillin/
Streptomycin (Thermo Fisher Scientiﬁc), 100 ng/mL Stem Cell Factor
(SCF, Prepotech), 100 ng/mL FLT-3 (Thermo Fisher Scientiﬁc),
20 ng/mL Interleukin-6 (IL-6) (Thermo Fisher Scientiﬁc), 20 ng/mL In-
terleukin-3 (IL-3) (Thermo Fisher Scientiﬁc). Themediumwas replaced
daily for 3 d.
Four days later, viral particles provided with the CytoTune-iPS 2.0
Sendai Reprogramming Kit (Thermo Fisher Scientiﬁc) were used tosuspension culture (5×). At D14 cultures expressed ectodermal (β3-Tubulin),mesodermal
parable expression levels of transcripts for the 3 germ-layers, FGF5 (ectoderm), Nestin
iated MMD ISCH#6 iPSCs and differentiated reference commercial hiPSCs.
Table 1
List of primers sequences, amplicons size and number of PCR cycles.
Gene Primers sequence Amplicon size Cycles (PCR)
β Actin Fw: GACAGGATGCAGAAGGAGATTACTG; Rev: CTCAGGAGGAGCAATGATCTTGAT 72 bp 25
OCT4 Fw: GGAAGGAATTGGGAACACAAAGG; Rev: AACTTCACCTTCCCTCCAACCA 71 bp 30
SOX2 Fw: GCTACAGCATGATGCAGGACCA; Rev: TCTGCGAGCTGGTCATGGAGTT 135 bp 30
c-Myc Fw: CCTGGTGCTCCATGAGGAGAC; Rev: CAGACTCTGACCTTTTGCCAGG 128 bp 30
KLF4 Fw: CATCTCAAGGCACACCTGCGAA; Rev: TCGGTCGCATTTTTGGCACTGG 156 bp 30
Nanog Fw: CCTGTGATTTGTGGGCCTG; Rev: GACAGTCTCCGTGTGAGGCAT 78 bp 30
SeV Fw: GGATCACTAGGTGATATCGAGC; Rev: ACCAGACAAGAGTTTAAGAGATATGTATC 181 bp 40
Nestin Fw: GGAGAAGGACCAAGAACTG; Rev: ACCTCCTCTGTGGCATTC 153 bp qRT-PCR
T-Brachyury Fw: CCTTCAGCAAAGTCAAGCTCACC; Rev: TGAACTGGGTCTCAGGGAAGCA 153 bp qRT-PCR
FGF5 Fw: GGAATACGAGGAGTTTTCAGCAAC; Rev: CTCCCTGAACTTGCAGTCATCTG 99 bp qRT-PCR
AFP Fw: GCAGAGGAGATGTGCTGGATTG; Rev: CGTGGTCAGTTTGCAGCATTCTG 113 bp qRT-PCR
β3-Tubulin Fw: TCAGCGTCTACTACAACGAGGC; Rev: GCCTGAAGAGATGTCCAAAGGC 120 bp qRT-PCR
GAPDH Fw: CCACTCCTCCACCTTTGAC; Rev: ACCCTGTTGCTGTAGCCA 102 bp qRT-PCR
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following the manufacturer's instructions. 16–18 d post-infection, colo-
nies with iPSC-like phenotype were identiﬁed, picked and transferred
into Geltrex-coated wells and fed Essential 8 medium (E8 medium;
Thermo Fisher Scientiﬁc), following the manufacture's instruction.
Self-renewing MMD ISCH#6 iPSC line and commercial hiPSC line
(GIBCO, Thermo Fisher Scientiﬁc) were routinely cultured in E8 medi-
um, with daily medium change. Cells were passaged every 3–4 d with
EDTA-based dissociation solution.
2.3. In vitro differentiation
hiPSCs were collected and dissociated in order to obtain cell clumps,
then plated in low attachment wells in 2 mL of conditioned medium
(E8 medium) and 2 mL of fresh E8 medium supplemented with
2 mg/mL of PVA (polyvinyl alcohol, Santa Cruz Biotechnology) and
10 μg/mL of Y-27632 ROCK inhibitor (Tebu-BIO). Two days after, cell
clumps were resuspended in 4 mL of 1:1 mix composed of Essential 6
medium (E6medium, ThermoFisher Scientiﬁc) and E8medium supple-
mentedwith 2mg/mL of PVA. From the subsequent day until the end of
the experiment cultures were maintained in E6 medium. At day 7,
established embryoid bodies (EBs) were collected and transferred on
Geltrex-coated wells, and let to differentiate for further 7 d.
2.4. RNA isolation, polymerase chain reaction (PCR) and quantitative-PCR
(qPCR)
RNAwas puriﬁedwith the TRIzol Reagent (Thermo Fisher Scientiﬁc)
following the manufacture's protocol. cDNA was obtained by reverse-
transcription with iScript cDNA Synthesis Kit (BioRad) and used to ver-
ify the expression of speciﬁc genes by RT-PCR (primers reported in
Table 1). qRT-PCR (quantitative RT-PCR) was performed using
SsoAdvanced Universal SYBR Green Supermix Kit (BioRad), followingTable 2
List of the antibodies used in for immunocytochemistry (IC) and Western blot (WB) assays, w
Antibody Company
TRA 1-60 Santa Cruz Biotech
Nanog Santa Cruz Biotech
SOX2 Millipore
OCT4 Santa Cruz Biotech
α-SMA Sigma
TROMA-1 Iowa DHB
β3-Tubulin Promega
Anti-rabbit HRP BioRad
Anti-mouse HRP BioRad
Anti-mouse IgM FITC Santa Cruz Biotech
Alexa Fluor IgG anti-rabbit 568 Life Technologies
Alexa Fluor IgG anti-rabbit 488 Life Technologies
Alexa Fluor IgG anti-mouse 568 Life Technologies
Alexa Fluor IgG anti-mouse 488 Life Technologiesthe recommended protocol. Data were analyzed according to the com-
parative ΔΔCt method and normalized by using GAPDH housekeeping
gene.
2.5. Immunoﬂuorescence analysis
Cells were ﬁxed in PFA 4% for 15 min at room temperature, perme-
abilizedwith Triton 0.3% for 10min at room temperature, and incubated
in blocking solution (FBS 5%, Triton 0.3% in PBS) for 1 h. Incubationwith
the primary antibodies was performed overnight at 4 °C in FBS 2%, Tri-
ton 0.2% with the antibodies reported in the Table 2. The signal was re-
vealed with the appropriate secondary antibodies (Table 2). Nuclei
were counterstained with Hoechst 33,258 (1 μg/mL; Thermo Fisher Sci-
entiﬁc). Pictures were detected with the microscope Leica DM IL Led
Fluo and acquiredwith the camera Leica DFC450 C (LeicaMicrosystem).
2.6. Western blot assay
Cells were lysed in RIPA buffer and 20 μg of total lysate were frac-
tionated on 8% SDS-polyacrylamide gel, blotted onto PVDF membranes
using the TransBlot Turbo apparatus (BioRad) and hybridized overnight
at 4 °C with the primary antibodies reported in the Table 2. The signal
was detected with appropriate HRP-conjugated secondary antibodies
(BioRad) and ECL Clarity system (BioRad), using the chamber UVITECH
Cambridge (Uvitech).
2.7. Karyotyping
Cell cultures were treated with 10 ng/mL colcemid (Gibco
KaryoMAX Colcemid solution in PBS, Thermo Fisher Scientiﬁc) for
16 h (overnight) at 37 °C. Metaphases were collected according to stan-
dard protocols: brieﬂy, PBS washed cells were treated with hypotonic
solution (0.075 M KCl for 15 min at room temperature), ﬁxed in aceticorking dilution and species in which they are produced.
Dilution Species
1:1000 (WB) 1:200 (IC) Mouse IgM
1:1000 (WB) 1:100 (IC) Mouse
1:2000 (WB) 1:300 (IC) Rabbit
1:1000 (WB) 1:100 (IC) Rabbit
1:1000 (IC) Mouse
1:100 (IC) Mouse
1:1000 (IC) Mouse
1:3000 Goat
1:3000 Goat
1:200 Goat
1:300 Goat
1:300 Goat
1:300 Goat
1:300 Goat
622 M. Cardano et al. / Stem Cell Research 17 (2016) 619–622acid/methanol (1:3 v/v) and air-dried metaphase spreads slides were
analyzed by QFQ banding. Microscope observation was performed
using a Nikon Eclipse 90i (Nikon Instruments) equippedwith the acqui-
sition and analysis Genikon software (Nikon Instruments).
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